Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?

Immune checkpoint inhibitors (ICIs) are drugs growingly employed in cancer immunotherapy which have significantly improved the prognosis of several tumours. ICIs act by restoring the “exhausted” immune system and increasing the number of T cells active against pathogens losing tolerogenic signalling...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzarà, Cecilia, Lombardi, Andrea, Gramegna, Andrea, Ori, Margherita, Gori, Andrea, Blasi, Francesco, Bandera, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476418/
https://www.ncbi.nlm.nih.gov/pubmed/37667178
http://dx.doi.org/10.1186/s12879-023-08537-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476418/
https://www.ncbi.nlm.nih.gov/pubmed/37667178
http://dx.doi.org/10.1186/s12879-023-08537-w

Ejemplares similares